abstract aim: to assess the symptomatic efficacy of lactobacillus plantarum 299v (l. plantarum 299v) (dsm 9843) for the relief of abdominal symptoms in a large subset of irritable bowel syndrome (ibs) patients fulfilling the rome iii criteria.